Budesonide/formoterol powder (Hangzhou Chance Pharmaceuticals)

布地奈德/福莫特罗吸入粉雾剂 (杭州畅溪制药)

Report date: 2026/04/28 20:00:22

Base Information

Drug NameBudesonide/formoterol powder (Hangzhou Chance Pharmaceuticals)
Drug Alias Name福莫特罗/布地奈德 (杭州畅溪制药)CXG87CXG-87
ClassificationSmall molecules > Steroids
Mechanisms of ActionBeta-2 adrenergic receptor agonistsGlucocorticoid receptor agonists
TargetsBeta-2 adrenergic receptorGlucocorticoid receptor
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesHangzhou Chance Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Chance Pharmaceuticals Co LtdJewim Pharmaceutical (Shandong) Co Ltd
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A